Darren Candow
Darren Candow is a professor of kinesiology at the University of Regina. He studies creatine and resistance training, including how they affect muscle, bone, and physical function as people age.
Statements
43 statements
Darren Candow says creatine may lower some cytokines and compares the possible anti-inflammatory mechanism with the way COX inhibitors work.
Darren Candow says researchers should account for diet and new exercise routines when studying creatine. These changes can make it difficult to isolate the effect of the supplement.
Darren Candow says he reads the research as suggesting that creatine can increase lean mass and might reduce fat mass.
Darren Candow discusses a small study in young men whose upper arm was temporarily immobilized in a cast. Creatine helped preserve strength during immobilization compared with placebo. He offers reduced protein breakdown as a possible explanation.
Darren Candow says he does not know whether creatine changes the cross-education effect when one limb is immobilized and the opposite limb is trained. He presents this as a research question.
Darren Candow says one hypothesis is that taking creatine reduces how much the brain and liver need to make. He says production returns to baseline after supplementation stops.
Darren Candow argues in favor of considering creatine in pregnancy because the body already produces it. He compares his reasoning with how he thinks about protein from food or supplements.
Darren Candow says he is aware mainly of questionnaire data on creatine use during pregnancy and describes the difficulty of getting approval for research in this group.
Darren Candow says creatine from monohydrate is the same molecule in blood as creatine made in the liver. He uses that as part of his explanation for the safety profile he attributes to it.
Darren Candow explains that creatine draws water into cells. He notes that some people experience weight gain or gastrointestinal irritation and says he favors creatine monohydrate.
Darren Candow says creatine monohydrate is already highly bioavailable and questions marketing claims that other forms are absorbed better.
Darren Candow prefers taking creatine near a workout. He says the timing appears to make little difference and offers increased blood flow or transport during muscle contraction as a possible explanation for his preference.
Darren Candow describes experiments in which creatine and caffeine had opposite effects on how quickly muscle relaxed after contraction. He discusses the caffeine dose as one factor that could influence the interaction.
Darren Candow says he suspects caffeine, rather than the heat of a drink, might interfere with creatine.
Darren Candow distinguishes animal or cellular thermogenesis findings from the small body-fat changes he describes with creatine and weight training. He cautions that he does not expect large weight loss.
Darren Candow recounts how reports of cramps arose when some athletes also restricted water and says he has not seen evidence attributing the cramps to creatine.
Darren Candow says his group gave postmenopausal participants 11 grams of creatine a day and observed no adverse effects in that group.
Darren Candow discusses the idea that creatine could affect inflammation in the context of cancer research and points to a section written by Mark Tarnopolsky.
Darren Candow says creatine is not a diuretic and suggests that people may urinate more if they increase their fluid intake.
Darren Candow wonders whether taking more creatine could reduce the body's need to synthesize it and affect how it uses methyl groups. He says the cardiovascular findings are uncertain.
